Aarnio Emma, Martikainen Janne, Winn Aaron N, Huupponen Risto, Vahtera Jussi, Korhonen Maarit J
From the Department of Clinical Pharmacology, Tykslab, Turku University Hospital, Finland (E.A., R.H.); School of Pharmacy, University of Eastern Finland, Kuopio, Finland (E.A., J.M.); Department of Health Policy and Management, School of Public Health (A.N.W.) and Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy (M.J.K.), University of North Carolina at Chapel Hill; Department of Pharmacology, Drug Development and Therapeutics (R.H., M.J.K.) and Department of Public Health (J.V., M.J.K.), University of Turku, Finland; and Turku University Hospital, Finland (J.V.).
Circ Cardiovasc Qual Outcomes. 2016 Nov;9(6):704-713. doi: 10.1161/CIRCOUTCOMES.116.002728. Epub 2016 Oct 18.
Previous research shows that low socioeconomic position (SEP; especially low income) is associated with statin nonadherence. We investigated the relationship between SEP and statin adherence in a country with universal coverage using group-based trajectory modeling in addition to the proportion of days covered.
Using data from Finnish healthcare registers, we identified 116 846 individuals, aged 45 to 75 years, who initiated statin therapy for primary prevention of cardiovascular disease. We measured adherence as proportion of days covered over an 18-month period since initiation and identified different adherence patterns based on monthly adherence with group-based trajectory modeling. When adjusted for age, marital status, residential area, clinical characteristics, and copayment, low SEP was associated with statin nonadherence (proportion of days covered <80%) among men (eg, lowest versus highest income quintile: odds ratio, 1.41; 95% confidence interval, 1.32-1.50; basic versus higher-degree education: odds ratio, 1.18; 95% confidence interval, 1.13-1.24; unemployment versus employment: odds ratio, 1.17; 95% confidence interval, 1.10-1.25). Among women, the corresponding associations were different (<0.001 for sex-by-income quintile, sex-by-education level, and sex-by-labor market status interactions) and mainly nonsignificant. Results based on adherence trajectories showed that men in low SEP were likely to belong to trajectories presenting a fast decline in adherence.
Low SEP was associated with overall and rapidly increasing statin nonadherence among men. Conversely, in women, associations between SEP and nonadherence were weak and inconsistent. Group-based trajectory modeling provided insight into the dynamics of statin adherence and its association with SEP.
先前的研究表明,社会经济地位低下(SEP;尤其是低收入)与他汀类药物治疗依从性差有关。我们在一个全民医保的国家,除了计算服药天数比例外,还使用基于群组的轨迹模型研究了SEP与他汀类药物治疗依从性之间的关系。
利用芬兰医疗保健登记数据,我们识别出116846名年龄在45至75岁之间、开始使用他汀类药物进行心血管疾病一级预防治疗的个体。我们将依从性衡量为自开始治疗起18个月内的服药天数比例,并通过基于群组的轨迹模型根据每月依从性识别出不同的依从模式。在对年龄、婚姻状况、居住地区、临床特征和自付费用进行调整后,低SEP与男性他汀类药物治疗不依从(服药天数比例<80%)相关(例如,最低收入五分位数与最高收入五分位数相比:比值比,1.41;95%置信区间,1.32 - 1.50;基础教育与高等教育相比:比值比,1.18;95%置信区间,1.13 - 1.24;失业与就业相比:比值比,1.17;95%置信区间,1.10 - 1.25)。在女性中,相应的关联有所不同(收入五分位数、教育水平和劳动力市场状况的性别交互作用<0.001),且大多无统计学意义。基于依从性轨迹的结果表明,低SEP的男性更有可能属于依从性快速下降的轨迹。
低SEP与男性总体上以及迅速增加的他汀类药物治疗不依从有关。相反,在女性中,SEP与不依从之间的关联较弱且不一致。基于群组的轨迹模型为他汀类药物治疗依从性的动态变化及其与SEP的关联提供了深入了解。